… of patients during therapy and in the early diagnosis of cervical cancer. MicroRNAs (miRNAs) …
gene expression at posttranscriptional level by means of miRNA–messenger RNA (mRNA) …

… to therapy in cervical cancer. Here, we summarized various miRNAs as an employable …
for prognostic, diagnostic, and therapeutic biomarkers in the treatment of cervical cancer. …

… expression of microRNAs (miRNAs) in cervical cancer tissues and cells. Further studies
reveal that miRNAs play key roles in the initiation and progression of cervical cancer, via specific …

… miRNA modulation by HR-HPV oncoproteins (E5, E6, and E7), that could be translated into
clinical application … for developing therapeutic resistance and metastatic progression. Since …

… miRNAs implicated in cervical cancer are miR-21, miR-126, and miR-143, and clinical application
of these miRNAs … Methods for diagnosis of cervical cancer include analysis of changes …

… miRNAs in the development of CC and its treatment is one of these. Clinical uses of miRNAs
… the role of major miRNAs in cervical cancer development, progression, and drug resistance. …

… to broaden understanding of the functional role and potential clinical uses of miRNAs in CC.
… , their use in cervical cancer for diagnosis as well as clinical outcome prediction and therapy …

… to actual AS-ODNs clinical applications. By using combined … will be possible to apply TNAs
directly to the cancerous cervix to … of miRNAs (Oncomirs) are altered in cervical cancer as …

… on tumor and circulating miRNAs identified as significantly associated with the therapeutic
response in cervical cancer; … point of view sheds light on the challenges ahead in this tumor. …

… needed to determine the clinical implications of miRNA for cancer diagnosis and prognosis.
… to evolve, research into the clinical use of ASO as a therapy for CC is likely to move quickly. …